These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 5676640)

  • 21. [Blood clotting diagnosis with chromogenic substrates].
    Róka L; Rasche H
    Internist (Berl); 1980 Apr; 21(4):189-94. PubMed ID: 6998907
    [No Abstract]   [Full Text] [Related]  

  • 22. The use of an automated analyzer in the evaluation of antithrombin III and heparin.
    Scully MF
    Semin Thromb Hemost; 1983 Oct; 9(4):309-20. PubMed ID: 6658462
    [No Abstract]   [Full Text] [Related]  

  • 23. [Simple search test in pre- and postoperative blood coagulation disorders].
    Encke A
    Z Prakt Anasth; 1970 Feb; 5(1):66-8. PubMed ID: 4256219
    [No Abstract]   [Full Text] [Related]  

  • 24. [Usefulness of a modified thrombin generation test in the diagnosis of chronometric hypercoagulability].
    Zawilska K; Furmaniuk J
    Acta Haematol Pol; 1972; 3(2):155-60. PubMed ID: 4655614
    [No Abstract]   [Full Text] [Related]  

  • 25. A multicenter clinical evaluation of the Clot Signature Analyzer.
    Fricke W; Kouides P; Kessler C; Schmaier AH; Krijanovski Y; Jagadeesan K; Joist J
    J Thromb Haemost; 2004 May; 2(5):763-8. PubMed ID: 15099283
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The value of indices of morphological dissociation of the blood in the diagnosis of vascular diseases of the lower extremities].
    Dekster BG
    Vestn Khir Im I I Grek; 1966 Oct; 97(10):66-71. PubMed ID: 6001779
    [No Abstract]   [Full Text] [Related]  

  • 27. [THROMBOSIS, ARTERIOSCLEROSIS AND HYPERCOAGULABILITY].
    ULUTIN ON; AKMAN N; OZCAN E
    Turk Tip Cemiy Mecm; 1963 Aug; 29():428-32. PubMed ID: 14088134
    [No Abstract]   [Full Text] [Related]  

  • 28. [Studies of thrombophilic syndromes. I. Coagulation changes in coronary arteriosclerosis, cerebral arteriosclerosis and peripheral artery arteriosclerosis].
    Neri Serneri GG; Paoletti P; Silvestrini E; Masotti G
    Riv Crit Clin Med; 1968; 68(3):211-37. PubMed ID: 5737876
    [No Abstract]   [Full Text] [Related]  

  • 29. [Various aspects of the pathogenesis of thrombophlebitis].
    Drevina AI; Grinshteĭn EIa
    Vestn Khir Im I I Grek; 1971 Oct; 107(10):67-70. PubMed ID: 5142241
    [No Abstract]   [Full Text] [Related]  

  • 30. Pharmacologic modulation of thrombin generation associated with human clots by human purified antithrombin alone or in the presence of low molecular weight heparin or unfractionated heparin.
    Meddahi S; Bara L; Fessi H; Samama MM
    Blood Coagul Fibrinolysis; 2000 Jan; 11(1):51-9. PubMed ID: 10691099
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Present state of heparin therapy].
    Blatrix C; Soulier JP; Vacheron A; Cornu P
    Presse Med (1893); 1969 Mar; 77(15):553-6. PubMed ID: 5796027
    [No Abstract]   [Full Text] [Related]  

  • 32. Detecting antithrombin deficiency may be a difficult task--more than one test is necessary.
    Kristensen SR; Rasmussen B; Pedersen S; Bathum L
    J Thromb Haemost; 2007 Mar; 5(3):617-8. PubMed ID: 17229050
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effect of multiple intravenous injections of heparin on the content of antithrombin III in healthy animals and experimental atherosclerosis].
    Kudriashov BA; Pastorova VE; Bazaz'ian GG; Liapina LA
    Vopr Med Khim; 1984; 30(1):82-6. PubMed ID: 6710943
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The VITA Project: population-based distributions of protein C, antithrombin III, heparin-cofactor II and plasminogen--relationship with physiological variables and establishment of reference ranges.
    Rodeghiero F; Tosetto A
    Thromb Haemost; 1996 Aug; 76(2):226-33. PubMed ID: 8865536
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The inhibition of the anticoagulant activity of heparin by platelets, brain phospholipids, and tissue factor.
    Ofosu FA; Cerskus AL; Hirsh J; Smith LM; Modi GJ; Blajchman MA
    Br J Haematol; 1984 Jun; 57(2):229-38. PubMed ID: 6733045
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Changes in the coagulation and anticoagulation blood system in patients with obliterating arteriosis in the course of complex treatment including anticoagulants].
    Skripnichenko DF; Saĭko NP
    Klin Khir (1962); 1977 Sep; (9):35-7. PubMed ID: 144210
    [No Abstract]   [Full Text] [Related]  

  • 37. Antithrombin 3 deficiency in maturity onset diabetes mellitus and atherosclerosis.
    Banerjee RN; Sahni AL; Kumar V; Arya M
    Thromb Diath Haemorrh; 1974 May; 31(2):339-45. PubMed ID: 4850610
    [No Abstract]   [Full Text] [Related]  

  • 38. [OUR EXPERIENCE WITH THE OWREN TEST].
    CASTRO CM; GROIS J; GRILLI H; DESOLDATI L
    Dia Med; 1963 Nov; 35():1854-9. PubMed ID: 14099799
    [No Abstract]   [Full Text] [Related]  

  • 39. [Thrombosis patients with familial antithrombin-III deficiency treated with heparin and antithrombin].
    Brandt P
    Ugeskr Laeger; 1981; 143(34):2145-8. PubMed ID: 7281335
    [No Abstract]   [Full Text] [Related]  

  • 40. Evaluation of the in vitro detection of the hypercoagulable state using the thrombin generation test and plasma clot impedance test.
    Peck SD
    Thromb Haemost; 1979 Aug; 42(2):764-77. PubMed ID: 505379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.